[PRNewswire] Zymo Research Pays it Forward With Their Commitment to Eradicate
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
the COVID-19 Pandemic in India
-- DNA/RNA Shield - DirectDetect™ reagent eliminates RNA extraction for rapid deployment of COVID-19 tests in affected countries
(IRVINE, Calif., Sept. 28, 2021 PRNewswire=연합뉴스) Zymo Research has donated one million COVID-19 test kits that include its new DNA/RNA Shield - DirectDetect™ [https://www.zymoresearch.com/pages/directdetect?utm_source=PRNewswire&utm_medium=Press_Release&utm_campaign=DirectDetect_India_Donation_09.28.21 ] reagent and collection devices to Mapmygenome™ based in Hyderabad, India. Mapmygenome is a molecular diagnostics company that provides personalized DNA testing, COVID-19 testing, and genetic counseling to its customers. It offers personalized health solutions to its customers based on genetic tests. They have provided COVID-19 testing throughout the pandemic at their state-of-the-art molecular testing, cGLP-compliant laboratory as well as an onsite laboratory at the Rajiv Gandhi International Airport in Hyderabad, India where they test incoming passengers for the SARS-CoV-2 virus.
DNA/RNA Shield - DirectDetect, a reagent similar to Zymo Research's established DNA/RNA Shield™, safeguards viral RNA from degradation for safe, ambient temperature collection and transportation of samples without the need for nucleic acid extraction. Removing the nucleic acid extraction step reduces the time to get PCR test results. Compared to other reagents, DNA/RNA Shield - DirectDetect does not inhibit downstream RT-PCR. The DNA/RNA Shield - DirectDetect testing kit contains the DNA/RNA Shield - DirectDetect reagent with swab collection devices.
"DNA/RNA Shield - DirectDetect enables countries seeing an increase in COVID-19 cases to perform COVID-19 testing without extraction; therefore, removing the barrier of limited extraction resources. It's our way of providing humanitarian support to people in need," said Dr. Marc Van Eden, Vice President of Business Development at Zymo Research. "We teamed up with Mapmygenome because of their ability to rapidly deploy and analyze RT-PCR testing."
"In India, where testing supplies and vaccinations are difficult to obtain, testing is imperative to diagnosing the SARS-CoV-2 virus," said Anu Acharya, Founder and CEO of Mapmygenome. She continued, "While many biotechnology and testing suppliers have tended to concentrate on their domestic testing efforts, we appreciate Zymo Research's global humanitarian effort to help eradicate COVID-19."
For more information about DNA/RNA Shield - DirectDetect and Zymo Research's donation program, visit their website [https://www.zymoresearch.com/pages/directdetect?utm_source=PRNewswire&utm_medium=Press_Release&utm_campaign=DirectDetect_India_Donation_09.28.21 ].
About Zymo Research Corp.
Zymo Research is a privately owned company that has been serving the scientific and diagnostics community with state-of-the-art molecular biology tools since 1994. The company's vision "The Beauty of Science is to Make Things Simple" is reflected in all of their products, from epigenetics to DNA/RNA purification technologies. Historically recognized as the leader in epigenetics, Zymo Research is breaking boundaries with novel solutions for sample collection, microbiomic measurements, diagnostic devices, and NGS technologies that are high quality and simple to use. Follow Zymo Research on Facebook [https://www.facebook.com/zymoresearch ], LinkedIn [https://www.linkedin.com/company/zymo-research-corp/ ], Twitter [https://twitter.com/ZymoResearch ], and Instagram [https://www.instagram.com/zymoresearch/ ].
Photo - https://mma.prnewswire.com/media/1636888/Zymo_Research_Corp_Pays_Forward.jpg
Zymo Research pays it forward by donating one million DNA/RNA Shield - DirectDetect™ test kits to Mapmygenome™ based in Hyderabad, India.
Photo - https://mma.prnewswire.com/media/1636889/Anu_and_Minister_Photo2021_09_21_at_13_56_58__1.jpg
Anu Acharya, Founder and CEO of Mapmygenome (left) and K.T. Rama Rao, Minister for Municipal Administration & Urban Development, Industries & Commerce, and Information Technology of Telangana (right).
Logo - https://mma.prnewswire.com/media/364743/Zymo_Research_Corp_Logo.jpg
Zymo Research Corp. Logo
Source: Zymo Research Corp.
[편집자 주] 본고는 자료 제공사에서 제공한 것으로, 연합뉴스는 내용에 대해 어떠한 편집도 하지 않았음을 밝혀 드립니다.
(끝)
출처 : PRNewswire 보도자료
Copyright © 연합뉴스 보도자료. 무단전재 및 재배포 금지.
- 쓰레기 조절 못해 돈으로 때우는 지자체들…'벌금 폭탄' | 연합뉴스
- 尹-李 회담 의제는…현금지원·특검·거부권 등 논의될듯 | 연합뉴스
- 덥고 일교차 큰 주말…4월 최고기온 기록 경신할까 | 연합뉴스
- 개청 한 달 남은 우주청…인력 구성·임무 설정 등 과제 산적 | 연합뉴스
- 美국무 "중국이 北도발 중단 압박해달라…완전한 비핵화해야"(종합2보) | 연합뉴스
- 가자 휴전협상 진행중…'라파공격 막자' 중재국 총력전 | 연합뉴스
- [위클리 건강] "먹방·술방 시청이 건강 해친다…청소년 비만위험 22%↑" | 연합뉴스
- 의대교수들 "매주 1회 휴진…증원 발표하면 휴진기간 재논의" | 연합뉴스
- 경찰, 취임 앞둔 의협 차기회장 추가 압수수색…"정치보복" 반발(종합2보) | 연합뉴스
- 공수처, 국방부 법무관리관 14시간 조사…'채상병 의혹' 첫 소환(종합2보) | 연합뉴스